Pictured: A prescription bottle over a groovy neuro background/ Nicole Bean for BioSpace On Tuesday, an FDA advisory committee will meet to discuss the relative merits of Lykos Therapeutics’ psychedelic-assisted therapy for post-traumatic stress disorder—the first therapeutic for PTSD to undergo FDA scrutiny in this century. The recommendation of the FDA’s Psychopharmacologic Drugs Advisory Committee is non-binding and will be considered by the FDA on August 11, when it completes its New Drug...

Original publication date: April 3, 2020 When COVID-19 first appeared in the news, scientists began preparing for a widespread outbreak. The general population, however, wasn’t concerned. Many assumed it would be like the SARS pandemic, affecting relatively few people and, aside from a few cities or regions, not disrupting daily life. Severe acute respiratory syndrome (SARS) was called the first pandemic of the 21st century. It appeared in 2002 and quickly spread around the world. The Centers...